Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli, who was heavily criticized for raising the price of a drug used to treat a life-threatening infection by more than 4,000 percent, has been arrested by federal authorities.
Shkreli was arrested early Thursday morning and charged with securities fraud by federal prosecutors for allegedly plundering Retrophin, a biopharmaceutical company he used to run, for personal gain, a FBI spokeswoman and law enforcement officials confirmed to ABC News. Continue reading “Turing Pharmaceuticals CEO Martin Shkreli Arrested for Securities Fraud”